Back from irreversibility: use of percutaneous cardiopulmonary bypass for treatment of shock from refractory anaphylaxis during coronary intervention.

Chengot, Thomas; Goncalves, John; Marzo, Kevin

Chengot, Thomas; Goncalves, John; Marzo, Kevin.

Affiliation

Chengot T; Cardiology Department, Winthrop-University Hospital, Mineola, NY 11501, USA.

J Invasive Cardiol ; 21(6): e97-100, 2009 Jun.

Article in En | MEDLINE | ID: mdl-19494419

Subject(s)

Anaphylaxis/etiology; Anaphylaxis/surgery; Angioplasty, Balloon, Coronary/adverse effects; Cardiopulmonary Bypass; Contrast Media/adverse effects; Acute Coronary Syndrome/diagnosis; Acute Coronary Syndrome/therapy; Adrenergic Agonists/therapeutic use; Aged; Epinephrine/therapeutic use; Humans; Hypotension/chemically induced; Hypotension/drug therapy; Male; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Cardiopulmonary Bypass / Angioplasty, Balloon, Coronary / Contrast Media / Anaphylaxis Type of study: Diagnostic_studies Limits: Aged / Humans / Male Language: En Journal: J Invasive Cardiol Journal subject: CARDIOLOGIA Year: 2009 Document type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links